Arrowhead Pharmaceuticals
RNA-therapeutics company developing gene-silencing medicines for cardiometabolic, liver and pulmonary diseases.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Hypertriglyceridemia
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisPhase 3 · Recruiting · Severe Hypertriglyceridemia
Study of ARO-DIMERPA in Adult Participants With Mixed HyperlipidemiaPhase 1 · Recruiting · Hyperlipidemia; Mixed
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes MellitusPhase 1 · Recruiting · Obesity
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's DiseasePhase 1 · Recruiting · Alzheimer Disease
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes MellitusPhase 1 · Recruiting · Obesity
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/arrowhead-pharmaceuticals/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.